SCHEMBL2765229

SCHEMBL2765229

CCN(CC)CCCCC1CCCN(C(=O)c2ccc(N3CC(NC(=O)Oc4ccc(Br)s4)CC3=O)cc2C)C1

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.36
LMNA P02545 2/20 0.36
TP53 P04637 3/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 1/20 0.32
EEF2K O00418 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3285393 0.90 TP53 (0.38) POLBLMNATP53ALDH1A1
SCHEMBL2767007 0.89 LMNA (0.40) POLBLMNATP53MAPTALDH1A1
SCHEMBL2765619 0.87 POLB (0.41) POLBLMNATP53MAPTALDH1A1
SCHEMBL2765646 0.84 LMNA (0.43) POLBLMNATP53MAPT
SCHEMBL2765966 0.84 LMNA (0.43) POLBLMNATP53MAPTALDH1A1
SCHEMBL2768085 0.84 LMNA (0.40) POLBLMNATP53MAPT
SCHEMBL2766124 0.84 LMNA (0.44) POLBLMNATP53MAPT
SCHEMBL2765569 0.83 LMNA (0.46) POLBLMNATP53MAPT
SCHEMBL2767137 0.83 LMNA (0.46) POLBLMNATP53MAPT
SCHEMBL13376549 0.83 TP53 (0.38) POLBLMNATP53MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858890-B1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2010-04-14 EP disclosed
EP-1858890-A1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2007-11-28 EP disclosed
WO-2006089909-A1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-08-31 WO disclosed